AMFPF
Price
$16.49
Change
+$0.93 (+5.98%)
Updated
Jan 2 closing price
Capitalization
3.5B
Intraday BUY SELL Signals
ARRJF
Price
$3.50
Change
+$0.06 (+1.75%)
Updated
Jan 12 closing price
Capitalization
939.7M
Intraday BUY SELL Signals
Interact to see
Advertisement

AMFPF vs ARRJF

Header iconAMFPF vs ARRJF Comparison
Open Charts AMFPF vs ARRJFBanner chart's image
Amplifon S.p.A
Price$16.49
Change+$0.93 (+5.98%)
Volume$4.45K
Capitalization3.5B
Arjo AB
Price$3.50
Change+$0.06 (+1.75%)
Volume$300
Capitalization939.7M
AMFPF vs ARRJF Comparison Chart in %
AMFPF
Daily Signal:
Gain/Loss:
ARRJF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AMFPF vs. ARRJF commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMFPF is a Hold and ARRJF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (AMFPF: $16.49 vs. ARRJF: $3.49)
Brand notoriety: AMFPF and ARRJF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: AMFPF: 325% vs. ARRJF: 46%
Market capitalization -- AMFPF: $3.5B vs. ARRJF: $939.7M
AMFPF [@Medical Distributors] is valued at $3.5B. ARRJF’s [@Medical Distributors] market capitalization is $939.7M. The market cap for tickers in the [@Medical Distributors] industry ranges from $102.96B to $0. The average market capitalization across the [@Medical Distributors] industry is $12.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMFPF’s FA Score shows that 0 FA rating(s) are green whileARRJF’s FA Score has 1 green FA rating(s).

  • AMFPF’s FA Score: 0 green, 5 red.
  • ARRJF’s FA Score: 1 green, 4 red.
According to our system of comparison, ARRJF is a better buy in the long-term than AMFPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMFPF’s TA Score shows that 2 TA indicator(s) are bullish while ARRJF’s TA Score has 3 bullish TA indicator(s).

  • AMFPF’s TA Score: 2 bullish, 2 bearish.
  • ARRJF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, ARRJF is a better buy in the short-term than AMFPF.

Price Growth

AMFPF (@Medical Distributors) experienced а 0.00% price change this week, while ARRJF (@Medical Distributors) price change was +1.90% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +4.97%. For the same industry, the average monthly price growth was +10.92%, and the average quarterly price growth was +27.48%.

Industries' Descriptions

@Medical Distributors (+4.97% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMFPF($3.5B) has a higher market cap than ARRJF($940M). AMFPF has higher P/E ratio than ARRJF: AMFPF (27.60) vs ARRJF (20.03). AMFPF YTD gains are higher at: 6.011 vs. ARRJF (4.328). ARRJF has higher annual earnings (EBITDA): 1.97B vs. AMFPF (538M). ARRJF has more cash in the bank: 705M vs. AMFPF (237M). ARRJF has less debt than AMFPF: ARRJF (1.18B) vs AMFPF (1.89B). ARRJF has higher revenues than AMFPF: ARRJF (11.2B) vs AMFPF (2.41B).
AMFPFARRJFAMFPF / ARRJF
Capitalization3.5B940M372%
EBITDA538M1.97B27%
Gain YTD6.0114.328139%
P/E Ratio27.6020.03138%
Revenue2.41B11.2B21%
Total Cash237M705M34%
Total Debt1.89B1.18B160%
FUNDAMENTALS RATINGS
AMFPF vs ARRJF: Fundamental Ratings
AMFPF
ARRJF
OUTLOOK RATING
1..100
4943
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
17
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6783
PRICE GROWTH RATING
1..100
6348
P/E GROWTH RATING
1..100
8243
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRJF's Valuation (17) in the null industry is in the same range as AMFPF (34). This means that ARRJF’s stock grew similarly to AMFPF’s over the last 12 months.

ARRJF's Profit vs Risk Rating (100) in the null industry is in the same range as AMFPF (100). This means that ARRJF’s stock grew similarly to AMFPF’s over the last 12 months.

AMFPF's SMR Rating (67) in the null industry is in the same range as ARRJF (83). This means that AMFPF’s stock grew similarly to ARRJF’s over the last 12 months.

ARRJF's Price Growth Rating (48) in the null industry is in the same range as AMFPF (63). This means that ARRJF’s stock grew similarly to AMFPF’s over the last 12 months.

ARRJF's P/E Growth Rating (43) in the null industry is somewhat better than the same rating for AMFPF (82). This means that ARRJF’s stock grew somewhat faster than AMFPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMFPFARRJF
RSI
ODDS (%)
Bearish Trend 1 day ago
11%
Bearish Trend 1 day ago
14%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
25%
Bearish Trend 1 day ago
25%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
27%
Bullish Trend 1 day ago
13%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
26%
Bullish Trend 1 day ago
14%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
N/A
Bullish Trend 1 day ago
24%
View a ticker or compare two or three
Interact to see
Advertisement
AMFPF
Daily Signal:
Gain/Loss:
ARRJF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSHUX26.390.44
+1.70%
Kinetics Spin-Off and Corp Rest Instl
JCCIX17.040.06
+0.35%
JHancock Small Cap Core I
TCGCX23.72-0.10
-0.42%
Thornburg Small/Mid Cap Growth C
NLSCX18.72-0.09
-0.48%
Neuberger Berman Long Short C
LMGAX27.67-0.24
-0.86%
Lord Abbett Growth Opportunities A

AMFPF and

Correlation & Price change

A.I.dvisor tells us that AMFPF and COSM have been poorly correlated (+2% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AMFPF and COSM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMFPF
1D Price
Change %
AMFPF100%
N/A
COSM - AMFPF
2%
Poorly correlated
-4.66%
NSVGF - AMFPF
1%
Poorly correlated
N/A
SHPMY - AMFPF
0%
Poorly correlated
N/A
MAHLY - AMFPF
0%
Poorly correlated
N/A
ARRJF - AMFPF
-0%
Poorly correlated
N/A
More

ARRJF and

Correlation & Price change

A.I.dvisor tells us that ARRJF and SHPMF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARRJF and SHPMF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRJF
1D Price
Change %
ARRJF100%
N/A
SHPMF - ARRJF
8%
Poorly correlated
N/A
COSM - ARRJF
5%
Poorly correlated
-4.66%
MAHLY - ARRJF
2%
Poorly correlated
N/A
PDRX - ARRJF
0%
Poorly correlated
N/A
MEPDF - ARRJF
0%
Poorly correlated
N/A
More